Outcome of iron supplementation in well child practice

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20171024001

Enrollment

258

Registered

2017-10-24

Start date

2017-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron deficiency&#44

Interventions

placebo 1.1 ml/day,elixir ferrous sulfate 1.1 ml/day

Placebo Comparator Drug,Placebo Comparator Drug

placebo,intervention

Eligibility

Sex/Gender

All

Age

6 Months to No maximum

Inclusion criteria

Inclusion criteria: Infants born term at 6 month of age, Maternal had normal intrapartum screening for anemia Mother has iron supplementation during pregnancy and first 3 months of age Mothers donâ€™t have gestational hypertension or gestational diabetes

Exclusion criteria

Exclusion criteria: infant with cyanotic heart disease of anemia from any causes

Design outcomes

Primary

Measure	Time frame
hemoglobin level, serum iron level 6 months hemoglobin level g/dL, serum iron mcg/dL	—

Secondary

Measure	Time frame
developmental level 6 months cognitive score, language score and motor score	—

Countries

thailand

Contacts

Public Contactsureelak sutchritpongsa

Mahidol university

ssureelaknok@gmail.com0876676944

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026